Casdin-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
44
Total Value
1223806401
Accession Number
0000919574-25-003248
Form Type
13F-HR
Manager Name
Casdin-Capital
Data Enrichment
95% identified
42 identified2 unidentified

Holdings

44 positions
Manager:
Search and click to pin securities to the top
Page 2 of 3
578784100
Shares:946.4K
Value:$10.4M
2seventy bio, Inc.
Shares:2.0M
Value:$9.9M
VERACYTE, INC.
Shares:276.3K
Value:$8.2M
GE HealthCare Technologies Inc.
Shares:100.0K
Value:$8.1M
Syndax Pharmaceuticals Inc
Shares:635.0K
Value:$7.8M
AGIOS PHARMACEUTICALS, INC.
Shares:250.0K
Value:$7.3M
Moderna, Inc.
Shares:225.0K
Value:$6.4M
Hims & Hers Health, Inc.
Shares:200.0K
Value:$5.9M
Tenaya Therapeutics, Inc.
Shares:6.7M
Value:$3.8M
Verastem, Inc.
Shares:600.0K
Value:$3.6M
Septerna, Inc.
Shares:553.3K
Value:$3.2M
Solid Biosciences Inc.
Shares:775.0K
Value:$2.9M
Absci Corp
Shares:973.3K
Value:$2.4M
Teladoc Health, Inc.
Shares:300.0K
Value:$2.4M
Century Therapeutics, Inc.
Shares:3.2M
Value:$1.5M
Dyne Therapeutics, Inc.
Shares:100.0K
Value:$1.0M
Contineum Therapeutics, Inc.
Shares:148.3K
Value:$1.0M
RECURSION PHARMACEUTICALS, INC.
Shares:165.3K
Value:$874.6K
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Shares:723.8K
Value:$854.0K
Prime Medicine, Inc.
Shares:367.2K
Value:$730.7K